Elliot Norry, the Chief Medical Officer of $ADAP ($ADAP), sold 5,584 shares of the company on 01-17-2025 for an estimated $3,243. We received data on the trade from a ...
Adaptimmune Therapeutics PLC – ADR (NASDAQ:ADAP) shares are trading higher by 15.8% to $1.17 during Friday’s session after the company and Galapagos entered a clinical collaboration to license ...
ADAP is down after merging with TCRR, while TCRR is up. The merger dilutes ADAP, but in return, it gets one year of additional cash and the TCRR pipeline for free. The merger looks like a smart deal ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Adaptimmune Therapeutics ( (ADAP)) just ...
Seeing as Adaptimmune Therapeutics PLC – ADR (NASDAQ:ADP) has experienced bearish sentiment from the aggregate hedge fund industry, logic holds that there lies a certain “tier” of money managers that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results